1
Chronic Respiratory Diseases Research Center (CRDRC), National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran
2
Medical Student Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Abstract
COVID-19 pneumonia has invaded the world and continues to expand. The current evidence of the immune system reaction to this viral pneumonia shows that the post-infectious immunity against the virus may be temporary, and the virus may reinfect the patients after healing from the previous one. Here is presented a 55-year-old female patient, as a known case of Hodgkin lymphoma, diagnosed with COVID-19 reinfection during 40 days. Such evidence may be helpful in further understanding the immunology of the disease.
Fakharian,A. , Ebrahimibagha,H. , Mirenayat,M. and Farahmandi,F. (2021). COVID-19 Reinfection in a Patient with Hodgkin Lymphoma: a Case Report. TANAFFOS (Respiration), 20(1), 71-74.
MLA
Fakharian,A. , , Ebrahimibagha,H. , , Mirenayat,M. , and Farahmandi,F. . "COVID-19 Reinfection in a Patient with Hodgkin Lymphoma: a Case Report", TANAFFOS (Respiration), 20, 1, 2021, 71-74.
HARVARD
Fakharian A., Ebrahimibagha H., Mirenayat M., Farahmandi F. (2021). 'COVID-19 Reinfection in a Patient with Hodgkin Lymphoma: a Case Report', TANAFFOS (Respiration), 20(1), pp. 71-74.
CHICAGO
A. Fakharian, H. Ebrahimibagha, M. Mirenayat and F. Farahmandi, "COVID-19 Reinfection in a Patient with Hodgkin Lymphoma: a Case Report," TANAFFOS (Respiration), 20 1 (2021): 71-74,
VANCOUVER
Fakharian A., Ebrahimibagha H., Mirenayat M., Farahmandi F. COVID-19 Reinfection in a Patient with Hodgkin Lymphoma: a Case Report. TANAFFOS (Respiration), 2021; 20(1): 71-74.
